Plain-English translation of NCT07367516 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a new medication called for people with esophageal cancer that has come back or spread to other parts of the body, and whose cancer did not respond to previous immunotherapy and chemotherapy treatments. The trial has two stages: first, researchers will check if the medication is safe and how well people tolerate it; then, they will measure how well it actually works against the cancer.
Many people with advanced esophageal cancer don't respond well to standard treatments like immunotherapy and chemotherapy, or their cancer stops responding over time. This medication is being tested to see if it offers a new option for people in this difficult situation.
You likely qualify if…
You likely don't qualify if…
You would receive injections of the medication on a regular schedule, with treatment cycles of either 21 or 28 days depending on which group you're assigned to. You would have regular clinic visits for blood tests and scans to check how well the medication is working and to monitor for any side effects. The study will also involve providing a tumor tissue sample for research purposes to help scientists understand who benefits most from this treatment.
AI-generated summary from trial data · Jul 5, 2026 · Not medical advice
China